StockData
Petros Pharmaceuticals, Inc. logo

Petros Pharmaceuticals, Inc. (PTPI) stock

PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.00+0.00 (+5.56%)

Close on Oct 19, 2026Market cap $135.07KP/E –Yield –

Petros Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Petros Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2024 was -$2.63M. For fiscal 2024 it was -$2.63M.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$2.63M–
FY2020Dec 31, 2020-$15.31M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$959.96K–
Q4 FY2020Dec 31, 2020-$4.52M–
Q3 FY2020Sep 30, 2020-$2.67M–
Q2 FY2020Jun 30, 2020-$5.74M–
Q1 FY2020Mar 31, 2020-$2.38M–

More Petros Pharmaceuticals figures

See a number that looks wrong?